BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 28349302)

  • 1. A Mutant Sumo Facilitates Quick Plasmid Construction for Expressing Proteins with Native N-termini After Tag Removal.
    Zhang Y; Fan Y
    Mol Biotechnol; 2017 May; 59(4-5):159-167. PubMed ID: 28349302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of SUMO fusion technology with traditional gene fusion systems: enhanced expression and solubility with SUMO.
    Marblestone JG; Edavettal SC; Lim Y; Lim P; Zuo X; Butt TR
    Protein Sci; 2006 Jan; 15(1):182-9. PubMed ID: 16322573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SUMO fusion technology for enhanced protein expression and purification in prokaryotes and eukaryotes.
    Peroutka Iii RJ; Orcutt SJ; Strickler JE; Butt TR
    Methods Mol Biol; 2011; 705():15-30. PubMed ID: 21125378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A His6-SUMO-eXact tag for producing human prepro-urocortin 2 in Escherichia coli for raising monoclonal antibodies.
    Liew OW; Ang CX; Peh YP; Chong PC; Ng YX; Hwang LA; Koh XY; Yip YM; Liu W; Richards AM
    J Immunol Methods; 2014 Jan; 403(1-2):37-51. PubMed ID: 24291344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxin Fused with SUMO Tag: A New Expression Vector Strategy to Obtain Recombinant Venom Toxins with Easy Tag Removal inside the Bacteria.
    Shimokawa-Falcão LH; Caporrino MC; Barbaro KC; Della-Casa MS; Magalhães GS
    Toxins (Basel); 2017 Feb; 9(3):. PubMed ID: 28264436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SUMO fusion technology for enhanced protein production in prokaryotic and eukaryotic expression systems.
    Panavas T; Sanders C; Butt TR
    Methods Mol Biol; 2009; 497():303-17. PubMed ID: 19107426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The YoaW signal peptide directs efficient secretion of different heterologous proteins fused to a StrepII-SUMO tag in Bacillus subtilis.
    Heinrich J; Drewniok C; Neugebauer E; Kellner H; Wiegert T
    Microb Cell Fact; 2019 Feb; 18(1):31. PubMed ID: 30732606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human SUMO fusion systems enhance protein expression and solubility.
    Wang Z; Li H; Guan W; Ling H; Wang Z; Mu T; Shuler FD; Fang X
    Protein Expr Purif; 2010 Oct; 73(2):203-8. PubMed ID: 20457256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of aggregation prone human interferon gamma and its mutant in highly soluble and biologically active form by SUMO fusion technology.
    Tileva M; Krachmarova E; Ivanov I; Maskos K; Nacheva G
    Protein Expr Purif; 2016 Jan; 117():26-34. PubMed ID: 26407523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tandem SUMO fusion vectors for improving soluble protein expression and purification.
    Guerrero F; Ciragan A; Iwaï H
    Protein Expr Purif; 2015 Dec; 116():42-9. PubMed ID: 26297996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and purification of soluble human APRIL in Escherichia coli using ELP-SUMO tag.
    Zhang J; Ma L; Zhang SQ
    Protein Expr Purif; 2014 Mar; 95():177-81. PubMed ID: 24412409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble expression of bioactive recombinant porcine-human chimeric uricase mutant employing MBP-SUMO fusion system.
    Zhou Z; Zhao H; Zhang L; Xie Q; Liu Q; Tong M; Yu X; Xiong S
    Protein Expr Purif; 2022 Jan; 189():105978. PubMed ID: 34562586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prokaryotic expression and mechanism of action of α-helical antimicrobial peptide A20L using fusion tags.
    Yi T; Sun S; Huang Y; Chen Y
    BMC Biotechnol; 2015 Aug; 15():69. PubMed ID: 26238108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simplifying protein expression with ligation-free, traceless and tag-switching plasmids.
    Durani V; Sullivan BJ; Magliery TJ
    Protein Expr Purif; 2012 Sep; 85(1):9-17. PubMed ID: 22728767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Application of pET SUMO Protein Expression System in Escherichia coli: Cloning, Expression, Purification, and Characterisation of Native Kras4B
    Tan MS; Teh YH; Ho KL; Stanslas J
    Protein J; 2020 Feb; 39(1):54-61. PubMed ID: 31620959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of TtrD, an expressing recombinant fusion tag, in Escherichia coli.
    Chen A; Zhang L; Gu S; Tang R; Xie Y; Ji C
    Protein Expr Purif; 2016 Apr; 120():65-71. PubMed ID: 26690374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant Production and Characterization of SAC, the Core Domain of Par-4, by SUMO Fusion System.
    Zhang J; Sun A; Dong Y; Wei D
    Appl Biochem Biotechnol; 2018 Apr; 184(4):1155-1167. PubMed ID: 28971310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel self-cleavage system for production of soluble recombinant protein in Escherichia coli.
    Feng Y; Xu Q; Yang T; Sun E; Li J; Shi D; Wu D
    Protein Expr Purif; 2014 Jul; 99():64-9. PubMed ID: 24727155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A family of E. coli expression vectors for laboratory scale and high throughput soluble protein production.
    Cabrita LD; Dai W; Bottomley SP
    BMC Biotechnol; 2006 Mar; 6():12. PubMed ID: 16509985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-level expression of soluble recombinant proteins in Escherichia coli using an HE-maltotriose-binding protein fusion tag.
    Han Y; Guo W; Su B; Guo Y; Wang J; Chu B; Yang G
    Protein Expr Purif; 2018 Feb; 142():25-31. PubMed ID: 28963004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.